TriSalus Life Sciences (TLSIW) Accumulated Depreciation & Amortization (2022 - 2026)

TriSalus Life Sciences has reported Accumulated Depreciation & Amortization for 5 years, with the latest figure at $135000.0 in Q1 2026.

• For the quarter ending Q1 2026, Accumulated Depreciation & Amortization fell 21.51% year-over-year to $135000.0; the trailing twelve-month figure through Mar 2026 stood at $135000.0 (down 21.51% YoY), and the FY2025 full-year result was $626000.0, down 15.86% from the prior year.
• Accumulated Depreciation & Amortization for Q1 2026 stood at $135000.0, down from $626000.0 in the prior quarter.
• The five-year high for Accumulated Depreciation & Amortization was $744000.0 in Q4 2024, with the low at $135000.0 in Q1 2026.
• Historically, Accumulated Depreciation & Amortization has averaged $426454.5 across 5 years, with a median of $398000.0 in 2022.
• Annual changes were most pronounced in 2023 — Accumulated Depreciation & Amortization soared 71.86% — and 2026, when it dropped 21.51%.
• TriSalus Life Sciences' Accumulated Depreciation & Amortization stood at $398000.0 in 2022, then jumped by 71.86% to $684000.0 in 2023, then increased by 8.77% to $744000.0 in 2024, then retreated by 15.86% to $626000.0 in 2025, then tumbled by 78.43% to $135000.0 in 2026.
• The last three Accumulated Depreciation & Amortization figures came in at $135000.0 (Q1 2026), $626000.0 (Q4 2025), and $500000.0 (Q3 2025), per Business Quant data.